DocGo Q1 revenue $96M (down 50% YoY); slashes 2025 guidance to $300-330M, expects negative adjusted EBITDA

DocGo Inc.

2025-Q1 EPS reported -$0.09 revenue$96,033,055

Q1 2025 revenue $96.0M vs $192.1M YoY; net loss $11.1M vs net income $10.6M.
Adjusted EBITDA loss $3.9M vs $24.1M YoY; GAAP gross margin 28.2% vs 32.8%.
Full-year revenue guidance lowered to $300-330M (from $410-450M); adjusted EBITDA loss of $20-30M expected.
Guidance revision driven by removal of all non-migrant Government Population Health revenue due to policy uncertainty.
Cash $103.1M; repurchased 1.95M shares for $5.8M; expects positive cash flow from migrant receivables.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.